Loading clinical trials...
Loading clinical trials...
Assessment of the Clinical Effectiveness of Standardized Olive Leaf Capsules; as a Co-therapy in the Treatment of Non-hospitalized COVID-19 Patients; a Randomized Clinical Trial
Conditions
Interventions
Nusapure standardized olive leaves capsule, 750 mg (50% oleuropein)
Locations
1
Egypt
Shimaa Abdelgawad
Al Fayyum, Egypt
Start Date
May 10, 2021
Primary Completion Date
March 1, 2022
Completion Date
August 1, 2022
Last Updated
February 8, 2023
NCT05958316
NCT07189936
NCT06402318
NCT04525716
NCT03188796
NCT04527315
Lead Sponsor
Shimaa M. Abdelgawad
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions